DexCom (NASDAQ:DXCM – Get Free Report) had its price objective upped by equities researchers at Raymond James from $147.00 to $151.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price objective indicates a potential upside […]
DexCom (NASDAQ:DXCM – Get Free Report) had its price objective lifted by equities research analysts at Raymond James from $147.00 to $151.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price objective indicates a potential […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report)’s share price was down 2.6% during mid-day trading on Tuesday . The stock traded as low as $125.66 and last traded at $125.96. Approximately 291,262 shares changed hands during trading, a decline of 88% from the average daily volume of 2,525,369 shares. The stock had previously closed at […]
Column Capital Advisors LLC raised its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 14.6% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,617 shares of the medical device company’s stock after purchasing an additional 587 shares during the quarter. […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report)’s stock price dropped 2.6% on Tuesday . The company traded as low as $125.66 and last traded at $125.96. Approximately 291,262 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 2,525,369 shares. The stock had previously closed at $129.29. Analyst Ratings […]